Frequently Asked Questions
The market is segmented based on , By Drug Class (Tricyclic Obsessive compulsive disorder, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist and Reuptake Inhibitors, Others), Indication (Major Depressive Disorder, Anxiety Disorders, Attention Deficit Hyperactivity Disorder, Others), Route of Administration (Oral, Injectable, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) – Industry Trends and Forecast to 2029.
.
The Global Obsessive Compulsive Disorder Market size was valued at USD 505.10 USD Million in 2021.
The Global Obsessive Compulsive Disorder Market is projected to grow at a CAGR of 10.2% during the forecast period of 2022 to 2029.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
